Novartis and Sanofi nab DoD vaccine contracts

Novartis ($NVS) and Sanofi ($SNY) have both won contracts to supply the Department of Defense with flu vaccines. The contracts are worth more than $14 million each and have a completion date of September 30. Novartis is supplying vaccines to California and the United Kingdom, while Sanofi is responsible for Pennsylvania. Item

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.